Fellowship · Cincinnati, OH
Sponsored by Cincinnati Children's Hospital Medical Center
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial.
Lancet (London, England) · 2025 · 21 citations · Emily Gorell
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Orphanet journal of rare diseases · 2021 · 82 citations · Emily Gorell
Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
Journal of the American Academy of Dermatology · 2021 · 40 citations · Emily Gorell
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
Orphanet journal of rare diseases · 2022 · 37 citations · Emily Gorell
Potential role of the skin and gut microbiota in premenarchal vulvar lichen sclerosus: A pilot case-control study.
PloS one · 2021 · 29 citations · Kalyani Marathe
NASPAG Clinical Opinion: Diagnosis and Management of Lichen Sclerosis in Pediatric and Adolescent Patients.
Journal of pediatric and adolescent gynecology · 2022 · 14 citations · Kalyani Marathe
A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.
Orphanet journal of rare diseases · 2022 · 14 citations · Emily Gorell
Diagnosis and Care of the Newborn with Epidermolysis Bullosa.
NeoReviews · 2021 · 17 citations · Kalyani Marathe, Emily Gorell